Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(8)
Filter by content year
(-)
2020
(8)
Filter by form group
Filter by category
(-)
Collaborators
(8)
(-)
Financial
(8)
Other
(8)
All
(6)
Filter by category
Search
News
Pfizer und BioNTech geben potenzielle Liefervereinbarung mit der EU über 200 Millionen Dosen von mRNA-basierten Impfstoffkandidaten gegen SARS-CoV-2 bekannt
News
Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
News
Pfizer und BioNTech geben Vereinbarung mit dem Vereinigten Königreich über 30 Millionen Dosen eines mRNA-basierten Impfstoffkandidaten gegen SARS-CoV-2 bekannt
News
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
News
BioNTech schließt Übernahme von Neon Therapeutics ab
News
BioNTech Completes Acquisition of Neon Therapeutics
News
BioNTech übernimmt Neon um globale Führungsposition in T-Zell-Therapien zu stärken
News
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies